Trustworthy Clinical Decision Support Using Meta-Predicates and Domain-Specific Languages

📅 2026-04-23
📈 Citations: 0
Influential: 0
📄 PDF

career value

175K/year
🤖 AI Summary
Clinical decision support systems must balance accuracy with auditability, yet existing formal methods struggle to verify the epistemic appropriateness of evidence underlying clinical rules. This work proposes a domain-specific language (DSL) grounded in design-by-contract principles, introducing meta-predicates and an epistemic type system to categorize evidence by purpose, knowledge domain, scale, and acquisition method, while statically constraining the types of evidence permissible within rules. By uniquely integrating meta-predicates with an epistemic type system, the approach enables pre-deployment verification of evidence appropriateness and per-sample audit trails without compromising rule readability. Evaluation on the AnFiSA platform using 5.6 million genomic variants demonstrates that the framework effectively identifies epistemic errors in both AI-generated and human-authored rules, offering a trustworthy, independently auditable foundation for clinical AI decision support.

Technology Category

Application Category

📝 Abstract
\textbf{Background:} Regulatory frameworks for AI in healthcare, including the EU AI Act and FDA guidance on AI/ML-based medical devices, require clinical decision support to demonstrate not only accuracy but auditability. Existing formal languages for clinical logic validate syntactic and structural correctness but not whether decision rules use epistemologically appropriate evidence. \textbf{Methods:} Drawing on design-by-contract principles, we introduce meta-predicates -- predicates about predicates -- for asserting epistemological constraints on clinical decision rules expressed in a DSL. An epistemological type system classifies annotations along four dimensions: purpose, knowledge domain, scale, and method of acquisition. Meta-predicates assert which evidence types are permissible in any given rule. The framework is instantiated in AnFiSA, an open-source platform for genetic variant curation, and demonstrated using the Brigham Genomics Medicine protocol on 5.6 million variants from the Genome in a Bottle benchmark. \textbf{Results:} Decision trees used in variant interpretation can be reformulated as unate cascades, enabling per-variant audit trails that identify which rule classified each variant and why. Meta-predicate validation catches epistemological errors before deployment, whether rules are human-written or AI-generated. The approach complements post-hoc methods such as LIME and SHAP: where explanation reveals what evidence was used after the fact, meta-predicates constrain what evidence may be used before deployment, while preserving human readability. \textbf{Conclusions:} Meta-predicate validation is a step toward demonstrating not only that decisions are accurate but that they rest on appropriate evidence in ways that can be independently audited. While demonstrated in genomics, the approach generalises to any domain requiring auditable decision logic.
Problem

Research questions and friction points this paper is trying to address.

clinical decision support
auditability
epistemological constraints
regulatory compliance
evidence appropriateness
Innovation

Methods, ideas, or system contributions that make the work stand out.

meta-predicates
domain-specific language
epistemological validation
auditable AI
clinical decision support
M
Michael Bouzinier
Harvard University, Cambridge, MA, USA; IDEXX Laboratories, Westbrook, ME, USA; Forome Association, Newton, MA, USA
S
Sergey Trifonov
Forome Association, Newton, MA, USA
M
Michael Chumack
Forome Association, Newton, MA, USA
E
Eugenia Lvova
Forome Association, Newton, MA, USA; Deggendorf Institute of Technology, Germany
D
Dmitry Etin
Forome Association, Newton, MA, USA; Deggendorf Institute of Technology, Germany